ArticleBritish journal of cancer2020

Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.

Julien Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.